NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drugs may reverse fatty liver damage in new trial
Disease control CompletedThis study tests whether combining two diabetes drugs—semaglutide and empagliflozin—can reverse liver damage from NASH (a severe form of fatty liver disease) in people with type 2 diabetes. Participants will receive either the combo, empagliflozin alone, or a placebo for 48 weeks…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Phase: PHASE4 • Sponsor: German Diabetes Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can Omega-3 and diet advice tame fatty liver disease?
Disease control CompletedThis study investigates whether a nutrition education program and omega-3 supplements can help people with non-alcoholic fatty liver disease (NAFLD) lose weight, improve liver enzymes, and lower cholesterol. Participants are randomly assigned to receive nutrition guidance, omega-…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Phase: NA • Sponsor: Hawler Medical University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Milk thistle extract shows promise for fatty liver in new study
Disease control CompletedThis completed study looked at whether Legalon, a milk thistle extract, can help lower liver enzymes in people with non-alcoholic fatty liver disease (NAFLD) who also have metabolic syndrome. Over 360 adults took Legalon along with diet and exercise. The goal was to see if this c…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Sponsor: Mylan Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New ultrasound device could replace costly MRI for liver disease detection
Diagnosis CompletedThis study tests a new ultrasound-based device called the Liver Incytes System to see if it can measure liver stiffness and fat as accurately as MRI and FibroScan. The device uses sound waves to create images of the liver, similar to a traditional ultrasound. Researchers are enro…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Phase: NA • Sponsor: Sonic Incytes • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
New ultrasound software could simplify fatty liver diagnosis
Diagnosis CompletedThis study tested whether special software on standard ultrasound machines can accurately measure liver fat in people with non-alcoholic fatty liver disease (NAFLD). Researchers compared the ultrasound results to the Fibroscan CAP method in 25 adults. The goal was to see if the u…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Diagnosis
Last updated Jun 27, 2026 08:02 UTC